Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and Smoking
- 30 September 2000
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 14 (3) , 153-169
- https://doi.org/10.1006/brbi.1999.0574
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Smoking and Vulnerability for SchizophreniaSchizophrenia Bulletin, 1996
- Changes in Interleukin-1β and Soluble Interleukin-2 Receptor Levels in CSF and Serum of Schizophrenic PatientsJournal of Basic and Clinical Physiology and Pharmacology, 1995
- Mortality and Causes of Death in First Admitted Schizophrenic PatientsThe British Journal of Psychiatry, 1993
- The immune system is a key factor in the etiology of psychosocial diseaseMedical Hypotheses, 1991
- Lytic units reconsidered: Pitfalls in calculation and usageJournal of Clinical Laboratory Analysis, 1990
- Is schizophrenia an immunologic receptor disorder?Medical Hypotheses, 1983
- Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- A new immunodeficiency disorder in humans involving NK cellsNature, 1980
- Cancer mortality among patients in New York mental hospitalsCancer, 1967